3-D Matrix Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Jun Okada

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	16.3yrs
Participación del CEO	0.3%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	11.3yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Jun Okada (49 yo)

16.3yrs

Permanencia

Mr. Jun Okada serves as the President at 3-D Matrix, Ltd. Mr. Okada served as the Chief Executive Officer of 3-D Matrix, Ltd. since February 15, 2016.Mr. Okada served as an Executive Vice President at 3-D...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Jun Okada	President & Representative Director	16.3yrs	sin datos	0.30% ¥ 229.5k
Satoru Kobayashi	Head of Business Development & Director	2.3yrs	sin datos	0.050% ¥ 38.8k
Takao Miki	Head of EMEA Business & Director	2.3yrs	sin datos	sin datos
Robert Langer	Medical	no data	sin datos	sin datos
Shuguang Zhang	Medical	no data	sin datos	sin datos
Tatsutoshi Nakahata	Medical	no data	sin datos	sin datos
Keiji Nagano	Chairman of the Board	19.4yrs	sin datos	2.7% ¥ 2.1m
Tomoyuki Arai	Director	11.3yrs	sin datos	0.070% ¥ 54.0k
Kazuya Shimamura	Independent External Director	11.3yrs	sin datos	sin datos
Bengt Norden	Medical	no data	sin datos	sin datos
Yoshiaki Harino	Medical	no data	sin datos	sin datos
Takashi Noguchi	Medical	no data	sin datos	sin datos

11.3yrs

Permanencia media

51yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de DMTR.F son experimentados ( 11.3 años antigüedad media).

3-D Matrix Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

3-D Matrix, Ltd., Annual General Meeting, Jul 27, 2023

3-D Matrix, Ltd., Annual General Meeting, Jul 28, 2022

Recent updates

3-D Matrix, Ltd. announced that it has received ¥22.62 million in funding from CVI Investments, Inc.

3-D Matrix, Ltd. announced that it expects to receive ¥22.62 million in funding from CVI Investments, Inc.

3-D Matrix, Ltd. to Report Q3, 2024 Results on Mar 13, 2024

3-D Matrix, Ltd. to Report Q2, 2024 Results on Dec 13, 2023

3-D Matrix, Ltd. to Report Q1, 2024 Results on Sep 13, 2023

3-D Matrix, Ltd., Annual General Meeting, Jul 27, 2023

3-D Matrix, Ltd. to Report Fiscal Year 2023 Results on Jun 14, 2023

3-D Matrix, Ltd. to Report Q3, 2023 Results on Mar 17, 2023

3-D Matrix, Ltd. to Report Q2, 2023 Results on Dec 13, 2022

3-D Matrix, Ltd. announced that it has received ¥2.059835568 billion in funding from CVI Investments, Inc.

3-D Matrix, Ltd. announced that it expects to receive ¥2.059835568 billion in funding from CVI Investments, Inc.

3-D Matrix, Ltd. to Report Q1, 2023 Results on Sep 14, 2022

3-D Matrix, Ltd., Annual General Meeting, Jul 28, 2022

3-D Matrix, Ltd. to Report Fiscal Year 2022 Results on Jun 14, 2022

3-D Matrix, Ltd. announced that it expects to receive ¥1.7650936 billion in funding from CVI Investments, Inc.

3-D Matrix, Ltd. announced that it expects to receive ¥1.7650936 billion in funding from CVI Investments, Inc.

3-D Matrix, Ltd. announced that it has received ¥2.609 billion in funding from CVI Investments, Inc.

3-D Matrix, Ltd. announced that it expects to receive ¥2.609 billion in funding from CVI Investments, Inc.

3-D Matrix, Ltd. (JASDAQ:7777) signed contract to acquire 10% stake in PURMX Therapeutics Co., Ltd.

3-D Matrix, Ltd. to Report Q3, 2021 Results on Mar 16, 2021

3-D Matrix, Ltd. to Report Q2, 2021 Results on Dec 15, 2020

3-D Matrix, Ltd. announced that it expects to receive ¥216.0702 million in funding from CVI Investments, Inc.

3-D Matrix, Ltd. to Report Q1, 2021 Results on Sep 14, 2020

CEO

Permanencia

Miembros de la Junta

Permanencia media

Promedio de edad